Vadodara-based pharma player Alembic Pharmaceuticals Ltd on Wednesday said its wholly-owned arm, Alembic Pharmaceuticals INC, has acquired US-based generic drug developer Orit Laboratories LLC along with real estate owned by Okner Realty LLC.

Set up in August 2005 by Satish Patel, Orit has seven approved ANDAs and four ANDAs pending approval.

With a 8,600 sq ft R&D and manufacturing facility, Orit is focused on developing and filing oral solid and liquid products, the company said in a regulatory filing.

Apart from the existing ANDAs, Orit adds complementary skill-sets in soft gelatin based oral solids and oral liquids to Alembic with a team of eight highly experienced scientists.

Alembic Pharma shares ended at ₹503.05 on the NSE on Wednesday falling by 0.3 per cent over the previous close.